 |
|
|
| |
Lonafarnib/ritonavir with or without peginterferon achieves
rapid, durable responses in a chronic hepatitis D: extended
analyses from the phase 3 D-LIVR trialt
|
| |
| |
EASL 2026 May 26-30 Barcelona
Robert Taylor1, Ohad Etzion2, Saeed Sadiq Hamid3, Tarik Asselah4, 5, George Sebastian Gherlan6, Maria Buti7, Pietro Lampertico8, Adela Turcanu9, Tsarynna Petrivna10, Liana Gheorghe11, George Stancu11, Natalia Voronkova12, Natalia Barsukova13, Soo Aleman14, Jordan J. Feld15, Jean-Karl Sirois16, Armaan Hirani1, Hebaalla Agha1, Leen Kawas1, Nancy S. Reau17, Christopher Koh18, Theo Heller18, Cihan Yurdaydin19 , Xue Hua1, Jeffrey Glenn1, 20
|
| |
|
|
|
|
|
